Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis

Transl Neurodegener. 2024 Apr 11;13(1):20. doi: 10.1186/s40035-024-00413-0.

Yunqing Liu^#^{1

2}, Dejun Yan^#^{1

2}, Lin Yang^#^{3

4}, Xian Chen^{1

2}, Chun Hu^{5

6

7}, Meilan Chen⁸

¹ Key Laboratory of Brain, Cognition and Education Sciences, South China Normal University, Ministry of Education, Guangzhou, China.
² Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, China.
³ Department of Anesthesiology, the Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.
⁴ Rehabilitation Medicine Institute of Panyu District, Guangzhou, 511499, China.
⁵ Key Laboratory of Brain, Cognition and Education Sciences, South China Normal University, Ministry of Education, Guangzhou, China. [email protected].
⁶ Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, China. [email protected].
⁷ Guangdong Second Provincial General Hospital, Guangzhou, 510317, China. [email protected].
⁸ Guangdong Second Provincial General Hospital, Guangzhou, 510317, China. [email protected].

^# Contributed equally.

No abstract available

MeSH terms